Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bioscience Equity Partners (BEP) is a life sciences investment bank and fund manager founded three years ago, with roots dating back to 2005. The firm operates from multiple global financial hubs, including North America, Europe, and Asia-Pacific. BEP focuses on providing venture capital and funding solutions to early-stage companies in the biotech, med tech, and digital health sectors.
Bioscience Equity Partners invests in early-stage companies within the life sciences sector, specifically targeting biotech, med tech, and digital health. They provide venture capital, investment banking, and fund management services to support companies with transformative technologies. Their investment banking services include mergers and acquisitions, capital placements, and strategic advisory tailored to the complexities of the life sciences.
Email info@bioscienceequity.com with your deck to pitch to Bioscience Equity Partners.
Bioscience Equity Partners often leads investment rounds, particularly in the early stages of funding for biotech and healthcare companies.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth potential and align with their investment thesis.
Details about the specific size of their current fund are not publicly available, but they focus on early-stage investments in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.